
Quest Diagnostics Incorporated DGX
$ 195.87
0.14%
Annual report 2025
added 02-26-2026
Quest Diagnostics Incorporated Current Ratio 2011-2026 | DGX
Annual Current Ratio Quest Diagnostics Incorporated
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | 1.25 | 0.936 | 1.24 | 1.56 | 1.28 | 0.938 | 1.22 | 1.49 | 0.898 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.56 | 0.898 | 1.2 |
Current Ratio of other stocks in the Diagnostics research industry
| Issuer | Current Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
2.35 | - | -6.23 % | $ 30.6 M | ||
|
Biodesix
BDSX
|
1.27 | $ 15.21 | 3.54 % | $ 1.97 B | ||
|
Bioventus
BVS
|
1.5 | $ 9.12 | 1.33 % | $ 608 M | ||
|
Biomerica
BMRA
|
3.23 | $ 2.12 | -0.47 % | $ 4.87 M | ||
|
Fulgent Genetics
FLGT
|
13.4 | $ 16.37 | 0.24 % | $ 495 M | ||
|
Akumin
AKU
|
1.09 | - | -17.87 % | $ 25.9 M | ||
|
Enzo Biochem
ENZ
|
2.89 | - | -8.98 % | $ 14.8 K | ||
|
Check-Cap Ltd.
CHEK
|
0.206 | - | - | $ 9.42 M | ||
|
Lantheus Holdings
LNTH
|
1.96 | $ 75.01 | -0.96 % | $ 5.06 B | ||
|
Medpace Holdings
MEDP
|
1.3 | $ 460.9 | 0.87 % | $ 13.3 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
15.6 | - | - | $ 562 M | ||
|
Myriad Genetics
MYGN
|
2.09 | $ 4.77 | 2.36 % | $ 442 M | ||
|
National Research Corporation
NRC
|
1.12 | $ 17.42 | -0.51 % | $ 390 M | ||
|
DermTech
DMTK
|
1.88 | - | -11.32 % | $ 2.94 M | ||
|
Aspira Women's Health
AWH
|
1.63 | - | -6.19 % | $ 10.5 M | ||
|
Pacific Biosciences of California
PACB
|
1.01 | $ 1.39 | -0.36 % | $ 417 M | ||
|
Co-Diagnostics
CODX
|
10.2 | $ 4.4 | 101.83 % | $ 129 M | ||
|
Accelerate Diagnostics
AXDX
|
0.745 | - | -61.36 % | $ 2.46 M | ||
|
Global Cord Blood Corporation
CO
|
2.34 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
2.17 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
4.76 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
2.28 | - | 0.12 % | $ 80.1 M | ||
|
Precipio
PRPO
|
4.93 | $ 26.85 | -0.3 % | $ 34.8 M | ||
|
Personalis
PSNL
|
4.02 | $ 7.7 | 1.18 % | $ 456 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
1.15 | - | - | $ 10.7 B | ||
|
RadNet
RDNT
|
1.56 | $ 60.0 | -2.83 % | $ 4.51 B | ||
|
Charles River Laboratories International
CRL
|
1.82 | $ 159.79 | 1.13 % | $ 7.92 B | ||
|
IQVIA Holdings
IQV
|
1.28 | $ 165.38 | -0.95 % | $ 28.4 B | ||
|
Senseonics Holdings
SENS
|
1.94 | $ 6.74 | 1.81 % | $ 281 M | ||
|
Sotera Health Company
SHC
|
1.23 | $ 13.89 | 0.07 % | $ 3.94 B | ||
|
Biocept
BIOC
|
1.4 | - | -13.05 % | $ 7.29 M | ||
|
Invitae Corporation
NVTA
|
1.05 | - | - | $ 21.2 M | ||
|
BioNano Genomics
BNGO
|
2.52 | $ 1.24 | -15.07 % | $ 6.75 M | ||
|
Neuronetics
STIM
|
1.23 | $ 1.49 | -7.19 % | $ 98.3 M | ||
|
Mettler-Toledo International
MTD
|
0.994 | $ 1 256.48 | 1.41 % | $ 25.9 B | ||
|
Interpace Biosciences
IDXG
|
0.87 | $ 1.71 | 0.73 % | $ 7.5 M | ||
|
IDEXX Laboratories
IDXX
|
1.92 | $ 574.14 | -0.76 % | $ 46.2 B | ||
|
Illumina
ILMN
|
6.69 | $ 125.44 | 1.33 % | $ 19.9 B | ||
|
ICON Public Limited Company
ICLR
|
2.29 | $ 101.04 | 0.68 % | $ 8.33 B | ||
|
Guardant Health
GH
|
0.953 | $ 85.0 | 0.05 % | $ 10.7 B | ||
|
QIAGEN N.V.
QGEN
|
1.88 | - | - | $ 10.6 B | ||
|
Twist Bioscience Corporation
TWST
|
3.8 | $ 45.99 | 3.35 % | $ 2.75 B | ||
|
Celcuity
CELC
|
1.89 | $ 103.41 | -3.13 % | $ 4.08 B | ||
|
Chembio Diagnostics
CEMI
|
1.4 | - | 0.22 % | $ 16.8 M | ||
|
Laboratory Corporation of America Holdings
LH
|
1.89 | $ 265.75 | 0.5 % | $ 22.1 B | ||
|
Motus GI Holdings
MOTS
|
1.59 | - | -34.28 % | $ 263 K | ||
|
ENDRA Life Sciences
NDRA
|
2.35 | $ 3.36 | -3.45 % | $ 1.8 M | ||
|
NeoGenomics
NEO
|
2.6 | $ 8.05 | -0.62 % | $ 1.03 B | ||
|
Natera
NTRA
|
2.02 | $ 195.23 | -2.43 % | $ 19.2 B | ||
|
CareDx, Inc
CDNA
|
3.75 | $ 17.58 | 0.11 % | $ 937 M |